Valeant Outlines Heart Drug Discounts After Heavy Scrutiny

Valeant said Monday that it would expand discounts for a pair of its heart drugs following heavy scrutiny over its pricing tactics.

from WSJ.com: US Business http://ift.tt/1qnts41
via IFTTT